A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/36 (2006.01) A61L 2/00 (2006.01) B01D 37/00 (2006.01) B01D 61/14 (2006.01) C07K 1/34 (2006.01) C07K 14/75 (2006.01) C12N 7/02 (2006.01)
Patent
CA 2459690
The process starts with an adjusted purified fibrinogen solution, the adjusted purified solution is frozen and then thawed at a temperature between 5 and 20°C, the undissolved materials associated with the fibrinogen are subsequently separated, the temperature is adjusted and the resultant solution is finally subjected to nanofiltration using filters to a pore size smaller than 35 mm.
Le processus commence avec une solution de fibrinogène purifiée et ajustée; cette solution est congelée, puis décongelée jusqu'à l'atteinte d'une température se situant entre 5 et 20 degrés Celsius; ensuite, les matières non dissoutes associées avec le fibrinogène sont séparées, la température est ajustée, et la solution obtenue subit finalement une nanofiltration sur filtres dont les pores ont une taille inférieure à 35 mm.
Fernandez Rodriguez Jesus
Ristol Debart Pere
Grifols S.a.
Probitas Pharma S.a.
Robic
LandOfFree
Process for removing viruses in fibrinogen solutions and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for removing viruses in fibrinogen solutions and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for removing viruses in fibrinogen solutions and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1602617